应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00013 和黄医药
已收盘 04-25 16:09:09
30.350
+1.050
+3.58%
最高
31.250
最低
28.950
成交量
626.01万
今开
29.000
昨收
29.300
日振幅
7.85%
总市值
264.43亿
流通市值
264.43亿
总股本
8.71亿
成交额
1.90亿
换手率
0.72%
流通股本
8.71亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
和黄医药(00013)上涨5.12%,报30.8元/股
金融界 · 11:10
和黄医药(00013)上涨5.12%,报30.8元/股
和黄医药盘中异动 早盘快速拉升5.12%
自选股智能写手 · 11:10
和黄医药盘中异动 早盘快速拉升5.12%
和黄医药(00013)股价上升5.119%,现价港币$30.8
阿斯达克财经 · 11:09
和黄医药(00013)股价上升5.119%,现价港币$30.8
南向资金4月24日净买入和黄医药73.04万股 连续3日增持
自选股智能写手 · 09:31
南向资金4月24日净买入和黄医药73.04万股 连续3日增持
和黄医药04月24日主力资金流入822万元 连续3日加仓
自选股智能写手 · 04-24 16:15
和黄医药04月24日主力资金流入822万元 连续3日加仓
和黄医药:呋喹替尼美国上市两个月销售额达1510万美元
和讯网 · 04-23 16:01
和黄医药:呋喹替尼美国上市两个月销售额达1510万美元
和黄医药现涨超5% 机构指公司核心产品销售额保持较快增长
新浪港股 · 04-23 15:35
和黄医药现涨超5% 机构指公司核心产品销售额保持较快增长
港股异动 | 和黄医药(00013)午后涨近7% 呋喹替尼上市后放量迅速 多款重磅产品大适应症有望获批
智通财经 · 04-23 14:51
港股异动 | 和黄医药(00013)午后涨近7% 呋喹替尼上市后放量迅速 多款重磅产品大适应症有望获批
生物医药板块午后发力 药明合联(02268)涨8.59% 机构指行业今年依然有结构性增量
金吾财讯 · 04-23 13:53
生物医药板块午后发力 药明合联(02268)涨8.59% 机构指行业今年依然有结构性增量
和黄医药(00013)股价上升5.019%,现价港币$28.25
阿斯达克财经 · 04-23 13:38
和黄医药(00013)股价上升5.019%,现价港币$28.25
和黄医药04月19日遭主力抛售300万元 环比增加1775.00%
自选股智能写手 · 04-19
和黄医药04月19日遭主力抛售300万元 环比增加1775.00%
和黄医药04月15日主力资金流出474万元 连续3日减仓
自选股智能写手 · 04-15
和黄医药04月15日主力资金流出474万元 连续3日减仓
南向资金4月12日净卖出和黄医药41.00万股 连续3日减持
自选股智能写手 · 04-15
南向资金4月12日净卖出和黄医药41.00万股 连续3日减持
和黄医药(US ADR)下跌2.16%,报17.7美元/股
金融界 · 04-13
和黄医药(US ADR)下跌2.16%,报17.7美元/股
和黄医药4月11日遭南向资金减持117.47万股
自选股智能写手 · 04-12
和黄医药4月11日遭南向资金减持117.47万股
和黄医药04月10日主力资金流入483万元 连续3日加仓
自选股智能写手 · 04-10
和黄医药04月10日主力资金流入483万元 连续3日加仓
和黄医药(US ADR)上涨5.99%,报17.88美元/股
金融界 · 04-09
和黄医药(US ADR)上涨5.99%,报17.88美元/股
平安证券:维持和黄医药(00013)“推荐”评级 2023年业绩符合预期
智通财经 · 04-09
平安证券:维持和黄医药(00013)“推荐”评级 2023年业绩符合预期
和黄医药04月09日获主力加仓419万元 环比增加481.94%
自选股智能写手 · 04-09
和黄医药04月09日获主力加仓419万元 环比增加481.94%
港股异动 | 和黄医药(00013)现涨近6% 公司于AACR年会公布数据 呋喹替尼美国上市后放量迅速
智通财经 · 04-09
港股异动 | 和黄医药(00013)现涨近6% 公司于AACR年会公布数据 呋喹替尼美国上市后放量迅速
暂无数据
公司概况
公司名称:
和黄医药
所属市场:
SEHK
上市日期:
--
主营业务:
和黄医药(中国)有限公司(原名:和黄中国医药科技有限公司)是一家主要从事药品制造及销售的投资控股公司。连同其附属公司,该公司通过两个分部经营业务。肿瘤及免疫业务分部从事发现、开发和商业化用于治疗癌症和免疫性疾病的靶向疗法和免疫疗法,包括涵盖药物发现、开发、生产及监管职能的研发活动,以及支持研发业务的行政活动,还包括通过研发活动开发的药物的销售、推广、生产及分销。其他业务分部从事其他商业化业务,包括其他处方药物及非处方药物以及消费保健品的销售、推广、生产及分销。
发行价格:
--
{"stockData":{"symbol":"00013","market":"HK","secType":"STK","nameCN":"和黄医药","latestPrice":30.35,"timestamp":1714032549008,"preClose":29.3,"halted":0,"volume":6260125,"delay":0,"floatShares":871256270,"shares":871256270,"eps":0.9286441,"marketStatus":"已收盘","marketStatusCode":5,"change":1.05,"latestTime":"04-25 16:09:09","open":29,"high":31.25,"low":28.95,"amount":189621997,"amplitude":0.078498,"askPrice":30.4,"askSize":52000,"bidPrice":30.25,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":0.9286441288382944,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714095000000},"adr":0,"listingDate":1624982400000,"adjPreClose":29.3,"openAndCloseTimeList":[[1714008600000,1714017600000],[1714021200000,1714032000000]],"volumeRatio":2.111097,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00013/tweets","defaultTab":"tweets","newsList":[{"id":"2430627443","title":"和黄医药(00013)上涨5.12%,报30.8元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430627443","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430627443?lang=zh_cn&edition=full","pubTime":"2024-04-25 11:10","pubTimestamp":1714014609,"startTime":"0","endTime":"0","summary":"4月25日,和黄医药(00013)盘中上涨5.12%,截至11:10,报30.8元/股,成交7740.05万元。和黄医药(中国)有限公司是一家专注于全球市场的创新型医药研发企业,主要业务包括研发、生产、营销和经销抗肿瘤药物、处方药和消费保健产品。公司在全球范围内拥有多个上市药物,并在纳斯达克全球精选市场、香港交易所以及伦敦证交所的AIM市场上市。截至2023年年报,和黄医药营业总收入59.35亿元、净利润7.14亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/25111040400554.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430430244","title":"和黄医药盘中异动 早盘快速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430430244","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430430244?lang=zh_cn&edition=full","pubTime":"2024-04-25 11:10","pubTimestamp":1714014601,"startTime":"0","endTime":"0","summary":"2024年04月25日早盘11时10分,和黄医药股票出现异动,股价急速拉升5.12%。截至发稿,该股报30.800港元/股,成交量254.95万股,换手率0.29%,振幅6.31%。和黄医药股票所在的药品行业中,整体涨幅为0.24%。其相关个股中,中国医疗集团、兴科蓉医药、和黄医药涨幅较大,振幅较大的相关个股有联康生物科技集团、泰凌医药、三生制药,振幅分别为12.35%、8.00%、7.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042511100187e83654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042511100187e83654&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430443743","title":"和黄医药(00013)股价上升5.119%,现价港币$30.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2430443743","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430443743?lang=zh_cn&edition=full","pubTime":"2024-04-25 11:09","pubTimestamp":1714014540,"startTime":"0","endTime":"0","summary":"[上升股]和黄医药(00013) 股价在上午11:09比前收市价上升5.119%,现股价为港币$30.8。至目前为止,今日最高价为$30.8,而最低价为$28.95。总成交量为251.7万股,总成交金额为港币$7.572千万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404252162/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2430164414","title":"南向资金4月24日净买入和黄医药73.04万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2430164414","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430164414?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:31","pubTimestamp":1714008669,"startTime":"0","endTime":"0","summary":"4月24日, 南向资金增持和黄医药73.04万股,连续3日增持。截止当日收盘,港股通共持有和黄医药15261.28万股,占流通股17.51%。港股通增持金额前五个股分别为腾讯控股、中国银行、中国财险、中国石油化工股份、中国移动。和黄医药近5个交易日上涨10.36%,港股通累计增持100.21万股;近20个交易日上涨12.05%,港股通累计减持73.45万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042509435487acf705&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042509435487acf705&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429489839","title":"和黄医药04月24日主力资金流入822万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2429489839","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429489839?lang=zh_cn&edition=full","pubTime":"2024-04-24 16:15","pubTimestamp":1713946514,"startTime":"0","endTime":"0","summary":"04月24日, 和黄医药股价涨3.35%,报收29.30元,成交金额1.11亿元,换手率0.44%,振幅4.41%,量比1.38。和黄医药今日主力资金净流入822万元,连续3日净流入,上一交易日主力净流入326万元,今日环比增加152.15%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为38.46%,平均涨幅为4.75%。该股近5个交易日上涨10.36%,主力资金累计净流入1170万元;近20日主力资金累计净流出773万元,其中净流出天数为12日。该股主力净额占比0.03%,港股市场排名187/2629。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042416152787a9d752&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042416152787a9d752&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429216942","title":"和黄医药:呋喹替尼美国上市两个月销售额达1510万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429216942","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2429216942?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:01","pubTimestamp":1713859305,"startTime":"0","endTime":"0","summary":"快讯正文和黄医药午后股价急升5.39%,触及每股28.35港元截至发稿,和黄医药成交金额高达1.03亿港元。平安证券发布分析报告,指出该公司核心产品销售额实现迅猛增势,其拳头产品呋喹替尼在美国市场表现尤为抢眼。作为美国十年来首个获批治疗转移性结直肠癌的新药,呋喹替尼于2023年11月正式登陆美国市场。令人瞩目的是,上市短短两个月,其在美国市场的销售额迅速攀升至1510万美元,增长势头强劲。下载和讯APP查看快讯,体验更佳>>","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231728538b49fdc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231728538b49fdc9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429154728","title":"和黄医药现涨超5% 机构指公司核心产品销售额保持较快增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2429154728","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2429154728?lang=zh_cn&edition=full","pubTime":"2024-04-23 15:35","pubTimestamp":1713857700,"startTime":"0","endTime":"0","summary":"和黄医药(00013)午后上涨5.39%,现报28.35港元,成交额1.03亿港元。\n 平安证券指出,公司核心产品销售额保持较快增长,呋喹替尼在美国于2023年11月上市,是美国十多年来首个获批用于治疗转移性结直肠癌的创新靶向疗法,上市仅两个月,美国市场销售额已高达1510万美元,放量迅速。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-23/doc-inasvfmy9544885.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-23/doc-inasvfmy9544885.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429156706","title":"港股异动 | 和黄医药(00013)午后涨近7% 呋喹替尼上市后放量迅速 多款重磅产品大适应症有望获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2429156706","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429156706?lang=zh_cn&edition=full","pubTime":"2024-04-23 14:51","pubTimestamp":1713855096,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,和黄医药(00013)午后涨近7%,截至发稿,涨6.13%,报28.55港元,成交额9464.06万港元。平安证券指出,公司核心产品销售额保持较快增长,呋喹替尼在美国于2023年11月上市,是美国十多年来首个获批用于治疗转移性结直肠癌的创新靶向疗法,上市仅两个月,美国市场销售额已高达1510万美元,放量迅速。此外,公司多款重磅产品大适应症有望于24年获批或申报NDA,有望不断催化公司价值提升。该行表示,考虑到公司上市产品适应症仍在拓展,同时公司在研管线丰富,管线估值有望进一步提升,维持“推荐”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107417.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429027158","title":"生物医药板块午后发力 药明合联(02268)涨8.59% 机构指行业今年依然有结构性增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2429027158","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2429027158?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:53","pubTimestamp":1713851628,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块午后发力走高,药明合联 涨8.59%,荣昌生物涨6.53%,信达生物涨6.48%,康希诺生物涨6.4%,维亚生物涨5.88%,和黄医药涨5.58%,康方生物涨5.41%。华鑫证券表示,2024年1季度行业增长受到同期基数影响较为明显,如零售药店、POCT等,展望2024年全年,1季度高增长方向具有代表性,其增长趋势有望延续,医药行业依然有结构性增量。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/OTA2NWNmYzE4MTQyOTUwMjEyNTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OTA2NWNmYzE4MTQyOTUwMjEyNTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1935593","is_publish_highlight":false,"gpt_icon":0},{"id":"2429015849","title":"和黄医药(00013)股价上升5.019%,现价港币$28.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2429015849","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429015849?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:38","pubTimestamp":1713850680,"startTime":"0","endTime":"0","summary":"[上升股]和黄医药(00013) 股价在下午01:38比前收市价上升5.019%,现股价为港币$28.25。至目前为止,今日最高价为$28.25,而最低价为$26.9。总成交量为248.112万股,总成交金额为港币$6.853千万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404232989/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428172687","title":"和黄医药04月19日遭主力抛售300万元 环比增加1775.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428172687","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428172687?lang=zh_cn&edition=full","pubTime":"2024-04-19 16:15","pubTimestamp":1713514507,"startTime":"0","endTime":"0","summary":"04月19日, 和黄医药股价跌0.38%,报收26.00元,成交金额6946万元,换手率0.31%,振幅4.60%,量比1.06。和黄医药今日主力资金净流出300万元,上一交易日主力净流出16万元,今日环比增加1775.00%。该股近5个交易日下跌9.84%,主力资金累计净流出246万元;近20日主力资金累计净流出1342万元,其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191615128b3a1bfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191615128b3a1bfc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427025170","title":"和黄医药04月15日主力资金流出474万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2427025170","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427025170?lang=zh_cn&edition=full","pubTime":"2024-04-15 16:16","pubTimestamp":1713168976,"startTime":"0","endTime":"0","summary":"04月15日, 和黄医药股价跌2.59%,报收28.20元,成交金额7138万元,换手率0.29%,振幅3.97%,量比0.77。和黄医药今日主力资金净流出474万元,连续3日净流出,上一交易日主力净流出238万元,今日环比增加99.16%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为33.33%,平均跌幅为2.39%。该股近5个交易日上涨5.03%,主力资金累计净流入58万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入15万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161638877e8ea0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161638877e8ea0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427091775","title":"南向资金4月12日净卖出和黄医药41.00万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427091775","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427091775?lang=zh_cn&edition=full","pubTime":"2024-04-15 09:31","pubTimestamp":1713144667,"startTime":"0","endTime":"0","summary":"4月12日,南向资金减持和黄医药41.00万股连续3日减持。截止当日收盘,港股通共持有和黄医药15087.96万股,占流通股17.31%。和黄医药近5个交易日上涨10.71%,港股通累计减持294.22万股;近20个交易日上涨13.98%,港股通累计增持651.18万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150943538b23b564&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150943538b23b564&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427751466","title":"和黄医药(US ADR)下跌2.16%,报17.7美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2427751466","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2427751466?lang=zh_cn&edition=full","pubTime":"2024-04-13 02:50","pubTimestamp":1712947840,"startTime":"0","endTime":"0","summary":"4月13日,和黄医药(US ADR)(HCM)盘中下跌2.16%,截至02:50,报17.7美元/股,成交80.99万美元。财务数据显示,截至2023年12月31日,和黄医药(US ADR)收入总额8.38亿美元,同比增长96.52%;归母净利润1.01亿美元,同比增长127.93%。大事提醒:4月8日,和黄医药(US ADR)2023年四季度累计回购金额907.1万美元。5月22日,和黄医药(US ADR)将披露2024财年一季报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/13025040224624.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426721249","title":"和黄医药4月11日遭南向资金减持117.47万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426721249","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426721249?lang=zh_cn&edition=full","pubTime":"2024-04-12 09:31","pubTimestamp":1712885465,"startTime":"0","endTime":"0","summary":"4月11日,南向资金减持和黄医药117.47万股。截止当日收盘,港股通共持有和黄医药15128.96万股,占流通股17.35%。和黄医药近5个交易日上涨5.49%,港股通累计减持272.47万股;近20个交易日上涨21.52%,港股通累计增持720.13万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120941298b13c844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120941298b13c844&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426555184","title":"和黄医药04月10日主力资金流入483万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2426555184","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426555184?lang=zh_cn&edition=full","pubTime":"2024-04-10 16:15","pubTimestamp":1712736943,"startTime":"0","endTime":"0","summary":"04月10日, 和黄医药股价跌1.55%,报收28.50元,成交金额8728万元,换手率0.35%,振幅2.76%,量比0.79。和黄医药今日主力资金净流入483万元,连续3日净流入,上一交易日主力净流入419万元,今日环比增加15.27%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为38.46%,平均涨幅为4.75%。该股近5个交易日上涨6.53%,主力资金累计净流出1026万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入2520万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410161605875f6623&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410161605875f6623&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426903361","title":"和黄医药(US ADR)上涨5.99%,报17.88美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426903361","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426903361?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:00","pubTimestamp":1712671214,"startTime":"0","endTime":"0","summary":"4月9日,和黄医药(US ADR)(HCM)盘中上涨5.99%,截至22:00,报17.88美元/股,成交245.14万美元。财务数据显示,截至2023年12月31日,和黄医药(US ADR)收入总额8.38亿美元,同比增长96.52%;归母净利润1.01亿美元,同比增长127.93%。大事提醒:4月8日,和黄医药(US ADR)2023年四季度累计回购金额907.1万美元。5月22日,和黄医药(US ADR)将披露2024财年一季报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/09220040170551.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426154887","title":"平安证券:维持和黄医药(00013)“推荐”评级 2023年业绩符合预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2426154887","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426154887?lang=zh_cn&edition=full","pubTime":"2024-04-09 16:49","pubTimestamp":1712652542,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,平安证券发布研究报告称,考虑到公司上市产品适应症仍在拓展,同时在研管线丰富,管线估值有望进一步提升,维持和黄医药“推荐”评级,预计2024-2026年主营业务收入分别为6.71、8.61、10.27亿美元,净利润分别为-1.07、0.2、0.95亿美元,与之前保持一致。平安证券主要观点如下:核心产品销售额保持较快增长,呋喹替尼美国上市后放量迅速。2)呋喹替尼国内二线胃癌适应症23年4月获CDE受理,有望于24年获批上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099998.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426156405","title":"和黄医药04月09日获主力加仓419万元 环比增加481.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426156405","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426156405?lang=zh_cn&edition=full","pubTime":"2024-04-09 16:16","pubTimestamp":1712650580,"startTime":"0","endTime":"0","summary":"04月09日, 和黄医药股价涨7.82%,报收28.95元,成交金额1.99亿元,换手率0.80%,振幅9.87%,量比2.38。和黄医药今日主力资金净流入419万元,上一交易日主力净流入72万元,今日环比增加481.94%。该股近5个交易日上涨8.22%,主力资金累计净流出1603万元;近20日主力资金累计净流入2531万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091616538758d526&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091616538758d526&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426071539","title":"港股异动 | 和黄医药(00013)现涨近6% 公司于AACR年会公布数据 呋喹替尼美国上市后放量迅速","url":"https://stock-news.laohu8.com/highlight/detail?id=2426071539","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426071539?lang=zh_cn&edition=full","pubTime":"2024-04-09 10:22","pubTimestamp":1712629346,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,和黄医药(00013)现涨近6%,截至发稿,涨5.21%,报28.25港元,成交额5869.12万港元。消息面上,和黄医药此前公布,将于2024年4月5日至10日,在美国加利福尼亚州圣地亚哥召开的美国癌症研究协会(AACR)2024年年会上公布自主研发的化合物的数项研究的最新及更新后的数据。平安证券指出,呋喹替尼在全球三线结直肠癌市场保持领导地位,美国上市后放量迅速;呋喹替尼二线胃癌适应症获批可期,国内销售额峰值有望超20亿元;在研管线持续发力,多款重磅产品新适应症获批预期有望不断催化公司价值提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099793.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hutch-med.com","stockEarnings":[{"period":"1week","weight":0.1036},{"period":"1month","weight":0.0933},{"period":"3month","weight":0.3628},{"period":"6month","weight":-0.0051},{"period":"1year","weight":0.1743},{"period":"ytd","weight":0.0209}],"compareEarnings":[{"period":"1week","weight":0.0584},{"period":"1month","weight":0.0442},{"period":"3month","weight":0.061},{"period":"6month","weight":-0.0113},{"period":"1year","weight":-0.1232},{"period":"ytd","weight":0.009}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和黄医药(中国)有限公司(原名:和黄中国医药科技有限公司)是一家主要从事药品制造及销售的投资控股公司。连同其附属公司,该公司通过两个分部经营业务。肿瘤及免疫业务分部从事发现、开发和商业化用于治疗癌症和免疫性疾病的靶向疗法和免疫疗法,包括涵盖药物发现、开发、生产及监管职能的研发活动,以及支持研发业务的行政活动,还包括通过研发活动开发的药物的销售、推广、生产及分销。其他业务分部从事其他商业化业务,包括其他处方药物及非处方药物以及消费保健品的销售、推广、生产及分销。","exchange":"SEHK","name":"和黄医药","nameEN":"HUTCHMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和黄医药(00013)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和黄医药(00013)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和黄医药,00013,和黄医药股票,和黄医药股票老虎,和黄医药股票老虎国际,和黄医药行情,和黄医药股票行情,和黄医药股价,和黄医药股市,和黄医药股票价格,和黄医药股票交易,和黄医药股票购买,和黄医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和黄医药(00013)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和黄医药(00013)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}